1mg Technologies Pvt Ltd, a digital health platform start-up, today announced an additional investment from HBM as a further addition to its recently closed Series B financing. The company did not disclose the amount raised.
This is HBM’s first direct investment in a digital health company in this region.
HBM is among the global leaders in healthcare-focused investing with around $ 1 billion under management. HBM focuses on development stage, growth and buy-out financings of private companies as well as investments in public companies.
Prashant Tandon, co-founder of 1mg, said that at this key stage of growth, the company has a quality team in place and its business is backed by the best investors in the business across technology, healthcare and digital health.
The company claims 75 million annual visits on its platform.
According to Dr Andreas Wicki, CEO, HBM Healthcare Investments, “As a focused investor in healthcare, we have been monitoring the interesting impact that technology is having in the space of healthcare delivery. We believe 1mg has created a unique platform in one of the fastest growing markets in the world, and this platform can be the foundation of India’s leading healthcare services business in the years ahead. All companies in the healthcare domain are looking for innovative platforms to partner with to connect better with their consumers – very few platforms have managed to achieve the consumer engagement at scale like 1mg has done.”
The company has previously raised funding from Maverick Capital Ventures, Sequoia India, Omidyar Network, Kae Capital and Intel Capital.